	PCI is pleased to announce that further to the acquisition in September 2014 of 

 the company has rebranded as part of the PCI group. This rebrand expands PCI’s capability to deliver an integrated pharmaceutical service for global studies of investigational medicinal products and include manufacturing, packaging and labeling, QP and GMP consultancy, global distribution and returned drug management, as well as consultant services.

News

PCI is pleased to announce that further to the acquisition in September 2014 of Biotec Services International, the company has rebranded as part of the PCI group.